Healthcare Value Capital as of Dec. 31, 2015
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 19 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Biosante Pharmaceuticals (ANIP) | 25.8 | $16M | 345k | 45.12 | |
Albany Molecular Research | 13.2 | $8.0M | 402k | 19.85 | |
Qlt | 9.5 | $5.7M | 2.2M | 2.66 | |
Pfizer (PFE) | 8.0 | $4.8M | 150k | 32.28 | |
Quest Diagnostics Incorporated (DGX) | 7.8 | $4.7M | 66k | 71.14 | |
CryoLife (AORT) | 6.6 | $4.0M | 370k | 10.78 | |
Ultra Short Russell 2000 | 6.5 | $3.9M | 100k | 39.30 | |
DepoMed | 6.0 | $3.6M | 200k | 18.13 | |
Allergan | 5.2 | $3.1M | 10k | 312.50 | |
GlaxoSmithKline | 3.3 | $2.0M | 50k | 40.36 | |
Cytokinetics (CYTK) | 1.7 | $1.0M | 100k | 10.46 | |
Amarin Corporation (AMRN) | 1.2 | $756k | 400k | 1.89 | |
MannKind Corporation | 1.2 | $725k | 500k | 1.45 | |
Fibrocell Science | 1.1 | $672k | 148k | 4.55 | |
Zogenix | 0.8 | $469k | 32k | 14.73 | |
Pernix Therapeutics Holdings | 0.7 | $443k | 150k | 2.95 | |
Sorrento Therapeutics (SRNE) | 0.7 | $436k | 50k | 8.72 | |
Apricus Bioscience | 0.4 | $238k | 240k | 0.99 | |
Sunesis Pharmaceuticals | 0.2 | $135k | 150k | 0.90 |